2 Pyrrolizidine Alkaloids

Total Page:16

File Type:pdf, Size:1020Kb

2 Pyrrolizidine Alkaloids Uses Educational For http://sites.google.com/site/irdadeh/ ,09126599985,[email protected], Center Data Data Center ,09126599985,[email protected], For Educational Uses BLUK145-Gilbert March 5, 2008 22:30 Bioactive Compounds in Foods Bioactive Compounds in Foods Edited by John Gilbert and Hamide Z. Senyuva. © 2008 Blackwell Publishing Ltd, ISBN: 978-1-4051-5875-6 i Data Center ,09126599985,[email protected], For Educational Uses BLUK145-Gilbert March 5, 2008 22:30 Bioactive Compounds in Foods Edited by John Gilbert Central Science Laboratory, Sand Hutton, York, UK Hamide Z. S¸enyuva Scientific and Technological Research Council of Turkey (TUB¨ ITAK),˙ Ankara Test and Analysis Laboratory (ATAL), Ankara, Turkey iii Data Center ,09126599985,[email protected], For Educational Uses BLUK145-Gilbert March 5, 2008 22:30 This edition first published 2008 C 2008 by Blackwell Publishing Ltd Blackwell Publishing was acquired by John Wiley & Sons in February 2007. Blackwell’s publishing programme has been merged with Wiley’s global Scientific, Technical, and Medical business to form Wiley-Blackwell. Registered office John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, United Kingdom Editorial office 9600 Garsington Road, Oxford, OX4 2DQ, United Kingdom For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell. The right of the author to be identified as the author of this work has been asserted in accordance with the Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher. Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books. Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required, the services of a competent professional should be sought. Library of Congress Cataloging-in-Publication Data Bioactive compounds in foods/edited by John Gilbert, Hamide Z. S¸enyuva. p. cm. Includes bibliographical references and index. ISBN-13: 978-1-4051-5875-6 (hardback : alk. paper) ISBN-10: 1-4051-5875-1 (hardback : alk. paper) 1. Food–Analysis. 2. Food–Toxicology. 3. Food contamination. 4. Bioactive compounds I. Gilbert, John. II. Senyuva, Hamide Z. TX545.B56 2008 664.07–dc22 2007038437 A catalogue record for this book is available from the British Library. Set in 10/12 pt, Times by Aptara Inc., New Delhi, India Printed in Singapore by Markono Print Media Pte Ltd 1 2008 For the cover: Brown mushrooms photo c Alan Dunlop-Walters – Fotolia.com French fries photo c Anette Linnea Ras mussen – Fotolia.com Golden maize photo c AGphotographer – Fotolia.com Mixed vegetables photo c Michelle Marsan – Fotolia.com Mussels photo c Alison Bowden – Fotolia.com iv Data Center ,09126599985,[email protected], For Educational Uses BLUK145-Gilbert March 5, 2008 22:30 Contents Contributors xv PART ONE: NATURAL TOXICANTS 1 1 Introduction 3 John Gilbert and Hamide Z. S¸enyuva 1.1 Different perceptions of chemicals in food 3 1.2 Residues and contaminants in foods 4 1.3 Natural toxicants in foods 5 1.4 Developments in analytical methodology 6 1.5 Emerging risks 7 1.6 Bioactive compounds in foods 8 2 Pyrrolizidine Alkaloids 10 Colin Crews and Rudolf Krska Summary 10 2.1 Introduction 10 2.2 The pyrrolizidine alkaloids 11 2.3 Occurrence 12 2.3.1 Formation and function 13 2.4 Exposure 13 2.4.1 Contamination of foods 14 2.4.2 Pyrrolizidines in herbal preparations 15 2.5 Regulations 17 2.6 Toxicity and metabolism 17 2.6.1 General toxicity 17 2.6.2 Metabolism 18 2.6.3 Carcinogenicity and mutagenicity 18 2.7 Analytical methods 19 2.7.1 Extraction 20 2.7.2 Gas chromatography 20 2.7.3 High performance liquid chromatography 21 2.7.4 Other methods 22 Conclusions 24 References 24 Data Center ,09126599985,[email protected], For Educational Uses BLUK145-Gilbert March 5, 2008 22:30 vi Contents 3 Glucosinolates 31 Ruud Verkerk and Matthijs Dekker Summary 31 3.1 Introduction 31 3.2 Nature and occurrence 32 3.3 Biosynthesis 33 3.3.1 Amino acid modification 34 3.3.2 Conversion of amino acids 34 3.3.3 Secondary transformations 35 3.4 Hydrolysis 35 3.4.1 Myrosinase 35 3.4.2 Hydrolysis products 36 3.5 Analytical methods 38 3.5.1 Total glucosinolates 38 3.5.2 Individual glucosinolates 38 3.5.3 Breakdown products 40 3.6 Biological effects 40 3.6.1 Anticarcinogenicity 40 3.6.2 Toxicity 42 3.7 Taste versus health 43 3.8 Responses to stress factors 44 3.9 Effects of processing 44 Conclusions 47 References 47 4 Phycotoxins in Seafood 52 John W. Leftley and Fiona Hannah Summary 52 4.1 Introduction 52 4.2 Causative and vector organisms 52 4.3 Classification of phycotoxins 55 4.4 The saxitoxin (STX) group (PSP) 55 4.4.1 The toxins causing PSP: the saxitoxin family 58 4.4.2 Toxic effects 60 4.5 The okadaic acid (OA) group (DSP) 61 4.5.1 The toxins causing DSP: okadaic acid and the dinophysistoxins 64 4.5.2 Toxic effects 66 4.6 The domoic acid (DA) group (ASP) 68 4.6.1 The toxins causing ASP (DAP): domoic acid and its isomers 69 4.6.2 Toxic effects 69 4.7 The azaspiracid (AZA) group (AZP) 69 4.7.1 The toxins causing AZP: the azaspiracids 70 4.7.2 Toxic effects 71 4.8 The brevetoxin (BTX) group (NSP) 74 4.8.1 The toxins causing NSP: the brevetoxins 74 4.8.2 Toxic effects 75 Data Center ,09126599985,[email protected], For Educational Uses BLUK145-Gilbert March 5, 2008 22:30 Contents vii 4.9 The ciguatera toxin (CTX) group (CFP) 75 4.9.1 The toxins causing CFP 76 4.9.2 Toxic effects of CTXs 77 4.10 Other phycotoxins 77 4.10.1 The pectenotoxin group 77 4.10.2 The yessotoxin group 78 4.10.3 The cyclic imine group 80 4.10.4 The cyanobacterial toxins 82 4.10.5 Miscellaneous phycotoxins 83 4.11 Detection of phycotoxins in seafood and algae 83 4.11.1 Assays and analyses 84 4.11.2 Mammalian bioassays 85 4.11.3 Instrumental (physico-chemical) analysis 86 4.11.4 In vitro assays 87 4.12 Depuration of phycotoxins 88 4.12.1 Natural depuration 88 4.12.2 Studies on cooking as a method of depuration 89 4.12.3 The effects of freezing and chilling 91 4.13 Monitoring and regulation 92 4.13.1 Phytoplankton monitoring 92 4.13.2 Monitoring of shellfish tissues for toxicity 93 4.13.3 Risk analysis 93 4.14 Future prospects 96 4.15 A note on the IOC harmful algal bloom programme 96 Acknowledgements 97 References 97 5 Mushroom Toxins 110 Jana Hajslov´aand Vera Schulzova Summary 110 5.1 Introduction 110 5.2 Poisonous mushrooms 112 5.2.1 Amatoxins, phallotoxins and virotoxins 112 5.2.2 Orellanine 116 5.2.3 Muscarine 117 5.2.4 Ibotenic acid and muscimol 118 5.2.5 Psilocybin, psilocin 119 5.2.6 Coprine 121 5.3 Edible mushrooms 122 5.3.1 Gyromitrin 122 5.3.2 Agaritine and other phenylhydrazines 125 References 129 6 Mycotoxins 134 Keith A. Scudamore Summary 134 Data Center ,09126599985,[email protected], For Educational Uses BLUK145-Gilbert March 5, 2008 22:30 viii Contents 6.1 Introduction 134 6.1.1 Mycotoxins and their study 134 6.1.2 Mycotoxins and fungi 136 6.1.3 Sampling and detection 137 6.1.4 Significance and control 142 6.2 Aflatoxins 142 6.2.1 Chemical properties 142 6.2.2 Analytical methods 143 6.2.3 Occurrence in raw materials and processed foods 144 6.2.4 Toxicology 145 6.2.5 Regulation and control 146 6.3 Ochratoxin A 146 6.3.1 Chemical properties 146 6.3.2 Analytical methods 147 6.3.3 Occurrence in raw materials and processed foods 147 6.3.4 Toxicology 148 6.3.5 Regulation and control 148 6.4 Deoxynivalenol and the trichothecenes 149 6.4.1 Chemical properties 149 6.4.2 Analytical methods 150 6.4.3 Occurrence in raw materials and processed foods 151 6.4.4 Toxicology 151 6.4.5 Regulation and control 152 6.5 Zearalenone 153 6.5.1 Chemical properties 153 6.5.2 Analytical methods 153 6.5.3 Occurrence in raw materials and processed foods 154 6.5.4 Toxicology 154 6.5.5 Regulation and control 154 6.6 Fumonisins 155 6.6.1 Chemical properties 155 6.6.2 Analytical methods 155 6.6.3 Occurrence in raw materials and processed foods 156 6.6.4 Toxicology 156 6.6.5 Regulation and control 157 6.7 Patulin 157 6.7.1 Chemical properties 157 6.7.2 Analytical methods 157 6.7.3 Occurrence in raw materials and processed foods 158 6.7.4 Toxicology 158 6.7.5 Regulation and control 159 6.8 Other mycotoxins 159 6.8.1 Citrinin 159 6.8.2 Sterigmatocystin 160 6.8.3 Cyclopiazonic acid 160 6.8.4 Moniliformin 161 6.8.5 Alternaria toxins 161 References 162 Data Center ,09126599985,[email protected], For Educational Uses BLUK145-Gilbert March 5, 2008 22:30 Contents ix 7 Phytoestrogens 173 Don Clarke and Helen Wiseman Summary 173 7.1 Introduction 173 7.2 The structure of phytoestrogens 173 7.3 Occurrence
Recommended publications
  • Ayahuasca: Spiritual Pharmacology & Drug Interactions
    Ayahuasca: Spiritual Pharmacology & Drug Interactions BENJAMIN MALCOLM, PHARMD, MPH [email protected] MARCH 28 TH 2017 AWARE PROJECT Can Science be Spiritual? “Science is not only compatible with spirituality; it is a profound source of spirituality. When we recognize our place in an immensity of light years and in the passage of ages, when we grasp the intricacy, beauty and subtlety of life, then that soaring feeling, that sense of elation and humility combined, is surely spiritual. The notion that science and spirituality are somehow mutually exclusive does a disservice to both.” – Carl Sagan Disclosures & Disclaimers No conflicts of interest to disclose – I don’t get paid by pharma and have no potential to profit directly from ayahuasca This presentation is for information purposes only, none of the information presented should be used in replacement of medical advice or be considered medical advice This presentation is not an endorsement of illicit activity Presentation Outline & Objectives Describe what is known regarding ayahuasca’s pharmacology Outline adverse food and drug combinations with ayahuasca as well as strategies for risk management Provide an overview of spiritual pharmacology and current clinical data supporting potential of ayahuasca for treatment of mental illness Pharmacology Terms Drug ◦ Term used synonymously with substance or medicine in this presentation and in pharmacology ◦ No offense intended if I call your medicine or madre a drug! Bioavailability ◦ The amount of a drug that enters the body and is able to have an active effect ◦ Route specific: bioavailability is different between oral, intranasal, inhalation (smoked), and injected routes of administration (IV, IM, SC) Half-life (T ½) ◦ The amount of time it takes the body to metabolize/eliminate 50% of a drug ◦ E.g.
    [Show full text]
  • Toxicity Equivalence Factors for Marine Biotoxins Associated with Bivalve Molluscs TECHNICAL PAPER
    JOINT FAO/WHO Toxicity Equivalency Factors for Marine Biotoxins Associated with Bivalve Molluscs TECHNICAL PAPER Cover photograph: © FAOemergencies JOINT FAO/WHO Toxicity equivalence factors for marine biotoxins associated with bivalve molluscs TECHNICAL PAPER FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS WORLD HEALTH ORGANIZATION ROME, 2016 Recommended citation: FAO/WHO. 2016. Technical paper on Toxicity Equivalency Factors for Marine Biotoxins Associated with Bivalve Molluscs. Rome. 108 pp. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations (FAO) or of the World Health Organization (WHO) concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or products of manufacturers, whether or not these have been patented, does not imply that these are or have been endorsed or recommended by FAO or WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by FAO and WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall FAO and WHO be liable for damages arising from its use.
    [Show full text]
  • (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
    pharmaceuticals Review Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact Andreia Machado Brito-da-Costa 1 , Diana Dias-da-Silva 1,2,* , Nelson G. M. Gomes 1,3 , Ricardo Jorge Dinis-Oliveira 1,2,4,* and Áurea Madureira-Carvalho 1,3 1 Department of Sciences, IINFACTS-Institute of Research and Advanced Training in Health Sciences and Technologies, University Institute of Health Sciences (IUCS), CESPU, CRL, 4585-116 Gandra, Portugal; [email protected] (A.M.B.-d.-C.); ngomes@ff.up.pt (N.G.M.G.); [email protected] (Á.M.-C.) 2 UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal 3 LAQV-REQUIMTE, Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal 4 Department of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal * Correspondence: [email protected] (D.D.-d.-S.); [email protected] (R.J.D.-O.); Tel.: +351-224-157-216 (R.J.D.-O.) Received: 21 September 2020; Accepted: 20 October 2020; Published: 23 October 2020 Abstract: Ayahuasca is a hallucinogenic botanical beverage originally used by indigenous Amazonian tribes in religious ceremonies and therapeutic practices. While ethnobotanical surveys still indicate its spiritual and medicinal uses, consumption of ayahuasca has been progressively related with a recreational purpose, particularly in Western societies. The ayahuasca aqueous concoction is typically prepared from the leaves of the N,N-dimethyltryptamine (DMT)-containing Psychotria viridis, and the stem and bark of Banisteriopsis caapi, the plant source of harmala alkaloids.
    [Show full text]
  • Ayahuasca Characterization, Metabolism in Humans, And
    Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 2012 Ayahuasca characterization, metabolism in humans, and relevance to endogenous N,N- dimethyltryptamines Ethan Hamilton McIlhenny Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Medicine and Health Sciences Commons Recommended Citation McIlhenny, Ethan Hamilton, "Ayahuasca characterization, metabolism in humans, and relevance to endogenous N,N- dimethyltryptamines" (2012). LSU Doctoral Dissertations. 2049. https://digitalcommons.lsu.edu/gradschool_dissertations/2049 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. AYAHUASCA CHARACTERIZATION, METABOLISM IN HUMANS, AND RELEVANCE TO ENDOGENOUS N,N-DIMETHYLTRYPTAMINES A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and School of Veterinary Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy in The Interdepartmental Program in Veterinary Medical Sciences through the Department of Comparative Biomedical Sciences by Ethan Hamilton McIlhenny B.A., Skidmore College, 2006 M.S., Tulane University, 2008 August 2012 Acknowledgments Infinite thanks, appreciation, and gratitude to my mother Bonnie, father Chaffe, brother Matthew, grandmothers Virginia and Beverly, and to all my extended family, friends, and loved ones. Without your support and the visionary guidance of my friend and advisor Dr. Steven Barker, none of this work would have been possible. Special thanks to Dr.
    [Show full text]
  • Current Neuropharmacology, 2019, 17, 108-128 REVIEW ARTICLE
    108 Send Orders for Reprints to [email protected] Current Neuropharmacology, 2019, 17, 108-128 REVIEW ARTICLE ISSN: 1570-159X eISSN: 1875-6190 Ayahuasca: Psychological and Physiologic Effects, Impact Factor: Pharmacology and Potential Uses in Addiction and 4.068 Mental Illness BENTHAM SCIENCE Jonathan Hamilla, Jaime Hallaka,b, Serdar M. Dursuna and Glen Bakera,* aDepartment of Psychiatry (Neurochemical Research Unit) and Neuroscience & Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada; bDepartment of Neurosciences and Behavior and National Institute of Science and Technology (Translational Medicine), Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil Abstract: Background: Ayahuasca, a traditional Amazonian decoction with psychoactive proper- ties, is made from bark of the Banisteriopsis caapi vine (containing beta-carboline alkaloids) and leaves of the Psychotria viridis bush (supplying the hallucinogen N,N-dimethyltryptamine, DMT). Originally used by indigenous shamans for the purposes of spirit communication, magical experi- ences, healing, and religious rituals across several South American countries, ayahuasca has been incorporated into folk medicine and spiritual healing, and several Brazilian churches use it routinely to foster a spiritual experience. More recently, it is being used in Europe and North America, not only for religious or healing reasons, but also for recreation. Objective: To review ayahuasca’s behavioral effects, possible adverse effects, proposed mechanisms A R T I C L E H I S T O R Y of action and potential clinical uses in mental illness. Received: July 26, 2017 Method: We searched Medline, in English, using the terms ayahuasca, dimethyltryptamine, Banis- Revised: November 07, 2017 teriopsis caapi, and Psychotria viridis and reviewed the relevant publications.
    [Show full text]
  • Author's Personal Copy
    Author's personal copy Provided for non-commercial research and educational use only. Not for reproduction, distribution or commercial use. This chapter was originally published in the book Encyclopedia of Toxicology. The copy attached is provided by Elsevier for the author's benefit and for the benefit of the author's institution, for non-commercial research, and educational use. This includes without limitation use in instruction at your institution, distribution to specific colleagues, and providing a copy to your institution's administrator. All other uses, reproduction and distribution, including without limitation commercial reprints, selling or licensing copies or access, or posting on open internet sites, your personal or institution’s website or repository, are prohibited. For exceptions, permission may be sought for such use through Elsevier’s permissions site at: http://www.elsevier.com/locate/permissionusematerial From Hambright, K.D., Zamor, R.M., Easton, J.D., Allison, B., 2014. Algae. In: Wexler, P. (Ed.), Encyclopedia of Toxicology, 3rd edition vol 1. Elsevier Inc., Academic Press, pp. 130–141. ISBN: 9780123864543 Copyright © 2014 Elsevier, Inc. unless otherwise stated. All rights reserved. Academic Press Author's personal copy Algae KD Hambright and RM Zamor, Plankton Ecology and Limnology Laboratory, University of Oklahoma Biological Station, and Program in Ecology and Evolutionary Biology, University of Oklahoma, Norman, OK, USA JD Easton and B Allison, Plankton Ecology and Limnology Laboratory, University of Oklahoma Biological Station, University of Oklahoma, Kingston, OK, USA Ó 2014 Elsevier Inc. All rights reserved. This article is a revision of the previous edition article by Keiko Okamoto and Lora E. Fleming, volume 1, pp 68–76, Ó 2005, Elsevier Inc.
    [Show full text]
  • A Review of Chemical Defense in Poison Frogs (Dendrobatidae): Ecology, Pharmacokinetics, and Autoresistance
    Chapter 21 A Review of Chemical Defense in Poison Frogs (Dendrobatidae): Ecology, Pharmacokinetics, and Autoresistance Juan C. Santos , Rebecca D. Tarvin , and Lauren A. O’Connell 21.1 Introduction Chemical defense has evolved multiple times in nearly every major group of life, from snakes and insects to bacteria and plants (Mebs 2002 ). However, among land vertebrates, chemical defenses are restricted to a few monophyletic groups (i.e., clades). Most of these are amphibians and snakes, but a few rare origins (e.g., Pitohui birds) have stimulated research on acquired chemical defenses (Dumbacher et al. 1992 ). Selective pressures that lead to defense are usually associated with an organ- ism’s limited ability to escape predation or conspicuous behaviors and phenotypes that increase detectability by predators (e.g., diurnality or mating calls) (Speed and Ruxton 2005 ). Defended organisms frequently evolve warning signals to advertise their defense, a phenomenon known as aposematism (Mappes et al. 2005 ). Warning signals such as conspicuous coloration unambiguously inform predators that there will be a substantial cost if they proceed with attack or consumption of the defended prey (Mappes et al. 2005 ). However, aposematism is likely more complex than the simple pairing of signal and defense, encompassing a series of traits (i.e., the apose- matic syndrome) that alter morphology, physiology, and behavior (Mappes and J. C. Santos (*) Department of Zoology, Biodiversity Research Centre , University of British Columbia , #4200-6270 University Blvd , Vancouver , BC , Canada , V6T 1Z4 e-mail: [email protected] R. D. Tarvin University of Texas at Austin , 2415 Speedway Stop C0990 , Austin , TX 78712 , USA e-mail: [email protected] L.
    [Show full text]
  • Current Trends and Challenges for Rapid SMART Diagnostics at Point-Of-Site Testing for Marine Toxins
    sensors Review Current Trends and Challenges for Rapid SMART Diagnostics at Point-of-Site Testing for Marine Toxins Michael Dillon 1,2, Maja A. Zaczek-Moczydlowska 1, Christine Edwards 3, Andrew D. Turner 4 , Peter I. Miller 5 , Heather Moore 6, April McKinney 6, Linda Lawton 3 and Katrina Campbell 1,* 1 Institute for Global Food Security, School of Biological Sciences, Queen’s University Belfast, 19 Chlorine Gardens, Belfast BT9 5DL, UK; [email protected] (M.D.); [email protected] (M.A.Z.-M.) 2 Faculty of Health, Peninsula Medical School, University of Plymouth, Plymouth PL4 8AA, UK 3 School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen AB10 7GJ, UK; [email protected] (C.E.); [email protected] (L.L.) 4 Centre for Environment, Fisheries and Aquaculture Science, The Nothe, Barrack Road, Weymouth, Dorset DT4 8UB, UK; [email protected] 5 Plymouth Marine Laboratory, Remote Sensing Group, Prospect Place, Plymouth PL1 3DH, UK; [email protected] 6 Agri-Food and Biosciences Institute, 18a Newforge Lane, Belfast, Northern Ireland BT9 5PX, UK; [email protected] (H.M.); [email protected] (A.M.) * Correspondence: [email protected] Abstract: In the past twenty years marine biotoxin analysis in routine regulatory monitoring has advanced significantly in Europe (EU) and other regions from the use of the mouse bioassay (MBA) towards the high-end analytical techniques such as high-performance liquid chromatography (HPLC) Citation: Dillon, M.; Zaczek- with tandem mass spectrometry (MS). Previously, acceptance of these advanced methods, in pro- Moczydlowska, M.A.; Edwards, C.; gressing away from the MBA, was hindered by a lack of commercial certified analytical standards for Turner, A.D.; Miller, P.I.; Moore, H.; method development and validation.
    [Show full text]
  • Poisoning by Edible Fish
    246 JAccid Emerg Med 1997;14:246-251 REVIEW J Accid Emerg Med: first published as 10.1136/emj.14.4.246 on 1 July 1997. Downloaded from Ichthyosarcotoxism: poisoning by edible fish Iain C Grant The term ichthyosarcotoxism describes a variety cause different syndromes, and even within a of conditions arising as the result of poisoning recognised single disease entity there may be by fish flesh. Poisoning by shellfish and other wide variation in symptoms depending on the invertebrates is excluded, as is bacterial food fish eaten or the geographical area. All of this poisoning from contaminated fish. Although makes classification very difficult and conse- most of the conditions are experienced mainly quently no recognised classification exists. in warmer climates than Britain's, one form of Table 1 shows an attempt to classify the condi- fish poisoning is relatively common here, and tions by the type of clinical features and symp- others may be imported, either through toms usually seen. This arrangement is simpli- imported fish or by travellers. The conditions fied and there is some overlap between could present to any accident and emergency conditions, but for the physician faced with a (A&E) department, and increased awareness patient with likely fish poisoning it gives some of these disease entities may improve diagnosis guidance towards a specific diagnosis. and management. It has been suggested that the features of It has long been known that some normally ciguatera, tetraodon, and paralytic shellfish edible fish species may from time to time cause poisoning are similar and that these should be poisoning.
    [Show full text]
  • Analytix 5/2015
    Issue 5 • 2015 Riedel-de Haën® Kromega® Certified Reference Materials by Jaytee® pg. 3 HPLC Instrument Calibration Phytochemical Standards Marine Biotoxin CRMs Carotenoid Standards Glucuronide Drug Testing BAM-Certified Reference Materials High-Quality HPLC Buffers Water Monitoring in Cosmetics Feature Article Sigma-Aldrich®’s Collaboration – Quality and Trust 3 Kromega® Certified Reference Materials by Jaytee® Now Available at Sigma-Aldrich® Dr. Magdalena Ulman Standards 5 Phytochemical Standards New Products and New Brochure Available Dear Reader, 6 Marine Biotoxin CRMs Products from the National Research Council of Canada (NRC) Sigma-Aldrich® works continually to develop long-term Now Available through Sigma-Aldrich® relationships with suppliers who demonstrate excellent and consistent product quality. This includes not only reagents 8 Isomeric Distribution of Astaxanthin and standards, but also consumables needed for different analytical techniques. New Standards for all-trans, 9-cis and 13-cis Astaxanthin Our partners, such as Hellma® or Specac®, have already proven their outstanding 12 Traceability Means Reliability performance level and consulting experience in the areas of UV/VIS, fluorescence New Organic TraceCERT® CRMs for Chromatography and IR spectroscopy. This issue presents one of our newest important partners, who 14 Glucuronide Drug Testing Applications deliver innovative products and dependable service. by Mass Spectrometry Jaytee® is well respected among the UK’s largest pharmaceutical and chemical companies Certified Spiking Solutions® of Glucuronides as a quality lead supplier and service provider. The kromega range of Qualification Labware Standards for HPLC and UV Spectrophotometers is designed to provide you with a solid foundation for your HPLC and UV spectrophotometer instrumentation qualification. 16 New Hellma® TrayCell™ – Photometric Micro Volume Analysis in the Nanoliter Range The feature article in this issue focuses on Jaytee’s kromega standards and gives insight DNA/RNA – Simply Analyzed into this high-quality product group.
    [Show full text]
  • 2021 ACMT Annual Scientific Meeting Abstracts—Virtual
    Journal of Medical Toxicology https://doi.org/10.1007/s13181-021-00832-9 ANNUAL MEETING ABSTRACTS 2021 ACMT Annual Scientific Meeting Abstracts—Virtual Abstract: These are the abstracts of the 2021 American College of 001. Gender-Based Production of N-Acetyl-P-Benzoquinone Imine Medical Toxicology (ACMT) Annual Scientific Meeting. Included here Protein Adduct Formation With Therapeutic Acetaminophen are 178 abstracts that will be presented in April 2021, including research Administration studies from around the globe and the ToxIC collaboration, clinically significant case reports describing toxicologic phenomena, and encore Brandon J Sonn1, Kennon J Heard1,2, Susan M Heard2,Angelo research presentations from other scientific meetings. D'Alessandro1, Kate M Reynolds2, Richard C Dart2, Barry H Rumack1,2,AndrewAMonte1,2 Keywords: Abstracts - Annual Scientific Meeting - Toxicology 1University of Colorado Denver, Aurora, Colorado, USA. 2Rocky Investigators Consortium - Medical Toxicology Foundation Mountain Poison and Drug Center, Denver, Colorado, USA Correspondence: American College of Medical Toxicology (ACMT) Background: Acetaminophen (APAP)-associated transaminase elevation, 10645 N. Tatum Blvd Phoenix, AZ; [email protected] induced by N-acetyl-p-benzoquinone imine (NAPQI) protein adduction, re- mains a global concern. Distinct from known genetic, physiologic, and dos- Introduction: The American College of Medical Toxicology (ACMT) age associations dictating severity of hepatic injury, no known factors predict received 188 eligible research abstracts for consideration for presentation an absence of NAPQI protein adduct formation at therapeutic APAP dosing. at the 2021 Annual Scientific Meeting (ASM), including 85 research Hypothesis: Gender-based physiologies are predictive of APAP-induced studies and 103 case reports. Each abstract was reviewed in a blinded protein adduct formation at therapeutic doses.
    [Show full text]
  • Rapid Throughput Analysis Demonstrates That Chemicals With
    1521-0111/87/4/595–605$25.00 http://dx.doi.org/10.1124/mol.114.096701 MOLECULAR PHARMACOLOGY Mol Pharmacol 87:595–605, April 2015 Copyright ª 2015 by The American Society for Pharmacology and Experimental Therapeutics Rapid Throughput Analysis Demonstrates that Chemicals with Distinct Seizurogenic Mechanisms Differentially Alter Ca21 Dynamics in Networks Formed by Hippocampal Neurons in Culture Zhengyu Cao, Xiaohan Zou, Yanjun Cui, Susan Hulsizer, Pamela J. Lein, Heike Wulff, and Isaac N. Pessah State Key Laboratory of Natural Medicines and Jiangsu Provincial Key laboratory for TCM Evaluation and Translational Development, China Pharmaceutical University, Nanjing, P.R. China (Z.C., X.Z., Y.C.); Department of Molecular Biosciences, Downloaded from School of Veterinary Medicine (Z.C., Y.C., S.H., P.J.L., I.N.P.) and Department of Pharmacology, School of Medicine (H.W.), University of California, Davis, California Received November 10, 2014; accepted January 12, 2015 ABSTRACT molpharm.aspetjournals.org Primary cultured hippocampal neurons (HN) form functional net- KAR competitive antagonist CNQX [6-cyano-7-nitroquinoxaline- works displaying synchronous Ca21 oscillations (SCOs) whose 2,3-dione] (1-10 mM) normalized Ca21 dynamics to the prekainate patterns influence plasticity. Whether chemicals with distinct pattern. Pilocarpine lacked Phase I activity but caused a sevenfold seizurogenic mechanisms differentially alter SCO patterns was prolongation of Phase II SCOs without altering either their fre- investigated using mouse HN loaded with the Ca21 indicator fluo- quency or amplitude, an effect normalized by atropine (0.3–1 mM). 4-AM. Intracellular Ca21 dynamics were recorded from 96 wells 4-AP (1–30 mM) elicited a delayed Phase I response associated simultaneously in real-time using fluorescent imaging plate reader.
    [Show full text]